News

Waban, headquartered in Cambridge, Massachusetts, and with operations in Mumbai, India, will become the Waban Software Group within Phase Forward. The Waban Software acquisition extends Phase Forward’s portfolio

Mohd Asif, CFO of Halo Pharmaceutical, said: “Provident is a respected local bank that understands the New Jersey market and the needs of New Jersey’s pharmaceutical companies. That’s

After graduating from the Richard Ivey School of Business, Mr Thrasher spent over 30 years working around the globe for such blue chip companies as General Foods, McCormick,

According to Covidien, the SILS port is a single, flexible port that may be fitted through a small incision in the umbilicus that results in a single ‘hidden

The issuance of this patent reinforces the significance of this treatment option for ear, nose and throat (ENT) physicians and their patients, the company said. It is reported

Isotechnika, a Canada-based biopharmaceutical company, has reported positive 12-month follow-up data from the Phase IIb Promise trial evaluating its lead drug, voclosporin, a next generation calcineurin inhibitor, in

Pharmos Corporation, which discovers and develops therapeutics to treat diseases of the nervous system and autoimmune disorders, has issued 18 million shares of common stock and warrants exercisable

The proprietary, patented, and biocompatible polyvinyl alcohol polymer (PVA) membrane may reduce the risk of associated injury following anterior vertebral surgeries by providing a vessel cover, the company

According to Takeda, TAK-379 is an anti-diabetic agent categorized as an insulin sensitizer and was in the Phase II stage of development in the US and Europe, and